Skip to main content

Asthenopia

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Alcon
AlconFORT WORTH, TX
1 program
Contact lens with Multifocal OpticsN/A1 trial
Active Trials
NCT03585790Completed45Est. Nov 2018
Bausch + Lomb
Bausch + LombNJ - Bridgewater
1 program
Multifocal Contact LensN/A
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
1 program
Multifocal Contact LensN/A1 trial
Active Trials
NCT03544216Completed84Est. May 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AlconContact lens with Multifocal Optics
Bausch HealthMultifocal Contact Lens

Clinical Trials (2)

Total enrollment: 129 patients across 2 trials

NCT03585790AlconContact lens with Multifocal Optics

The Impact of Soft Contact Lens Attributes on Symptoms Associated With Digital Eye Strain in Symptomatic Soft Contact Lens Wearers

Start: Sep 2018Est. completion: Nov 201845 patients
N/ACompleted
NCT03544216Bausch HealthMultifocal Contact Lens

Accommodative Relief for Uncomfortable Non-Presbyopes

Start: Feb 2017Est. completion: May 201884 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.